Singapore Approves MSD’s Enflonsia for Infant RSV Prevention
Beyond the Seasonal Surge: How Monoclonal Antibodies are Redefining Infant RSV Prevention The landscape of pediatric medicine is undergoing a fundamental shift. For decades, the medical community has been largely reactive—treating respiratory infections like RSV after they have already taken hold in a child’s lungs. However, a recent milestone in Singapore, with the approval of … Read more